
# Title 21 - Food and Drugs
## Chapter I - Food and Drug Administration, Department of Health and Human Services
### Subchapter C - Drugs: General
#### PART 201 - LABELING
##### Subpart B - Labeling Requirements for Prescription Drugs and/or Insulin
###### ยง 201.57 Specific requirements on content and format of labeling for human prescription drug and biological products described in ยง 201.56(b)(1).
####### 1

(C)() If specific pharmacokinetic or pharmacodynamic studies have been carried out in the elderly, they must be described briefly in the "Geriatric use" subsection and in detail under the "Clinical Pharmacology" section. The "Clinical Pharmacology" and "Drug Interactions" sections ordinarily contain information on drug/disease and drug/drug interactions that is particularly relevant to the elderly, who are more likely to have concomitant illness and to use concomitant drugs.
